174 related articles for article (PubMed ID: 1241159)
1. Antimitotic activity of the potent tumor inhibitor maytansine.
Remillard S; Rebhun LI; Howie GA; Kupchan SM
Science; 1975 Sep; 189(4207):1002-5. PubMed ID: 1241159
[TBL] [Abstract][Full Text] [Related]
2. Antimitotic and antitubulin activity of the tumor inhibitor steganacin.
Wang RW; Rebhum LI; Kupchan SM
Cancer Res; 1977 Sep; 37(9):3071-9. PubMed ID: 560248
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the in vivo mitotic apparatus by glycols and metabolic inhibitors.
Rebhun LI; Jemiolo D; Ivy N; Mellon M; Nath J
Ann N Y Acad Sci; 1975 Jun; 253():362-77. PubMed ID: 1096720
[No Abstract] [Full Text] [Related]
4. Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoids.
Kupchan SM; Sneden AT; Branfman AR; Howie GA; Rebhun LI; McIvor WE; Wang RW; Schnaitman TC
J Med Chem; 1978 Jan; 21(1):31-7. PubMed ID: 563462
[TBL] [Abstract][Full Text] [Related]
5. Effects of new antimitotic antibiotics, ansamitocins, on the growth of murine tumors in vivo and on the assembly of microtubules in vitro.
Ootsu K; Kozai Y; Takeuchi M; Ikeyama S; Igarashi K; Tsukamoto K; Sugino Y; Tashira T; Tsukagoshi S; Sakurai Y
Cancer Res; 1980 May; 40(5):1707-17. PubMed ID: 6245801
[No Abstract] [Full Text] [Related]
6. Binding of maytansinoids to tubulin.
York J; Wolpert-DeFilippes MK; Johns DG; Sethi VS
Biochem Pharmacol; 1981 Dec; 30(23):3239-43. PubMed ID: 7317106
[No Abstract] [Full Text] [Related]
7. Change in the heterogeneous distribution of tubulin isotypes in mitotic microtubules of the sea urchin egg by treatment with microtubule depolymerizing or stabilizing drugs.
Oka MT; Arai T; Hamaguchi Y
Cell Struct Funct; 1991 Apr; 16(2):125-34. PubMed ID: 1860140
[TBL] [Abstract][Full Text] [Related]
8. Microtubule-disrupting effects of gallium chloride in vitro.
Perchellet EM; Ladesich JB; Collery P; Perchellet JP
Anticancer Drugs; 1999 Jun; 10(5):477-88. PubMed ID: 10477168
[TBL] [Abstract][Full Text] [Related]
9. Caulerpenyne interferes with microtubule-dependent events during the first mitotic cycle of sea urchin eggs.
Pesando D; Huitorel P; Dolcini V; Amade P; Girard JP
Eur J Cell Biol; 1998 Sep; 77(1):19-26. PubMed ID: 9808285
[TBL] [Abstract][Full Text] [Related]
10. Binding of maytansine to tubulin: competition with other mitotic inhibitors.
Lin CM; Hamel E; Wolpert-DeFilippes MK
Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):443-51. PubMed ID: 7255878
[TBL] [Abstract][Full Text] [Related]
11. Maytansine inhibits nucleotide binding at the exchangeable site of tubulin.
Huang AB; Lin CM; Hamel E
Biochem Biophys Res Commun; 1985 May; 128(3):1239-46. PubMed ID: 4004859
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of cytokinesis in sea urchin embryos by low concentrations of stypoldione, a marine natural product that reacts with sulfhydryl groups.
O'Brien ET; Asai DJ; Jacobs RS; Wilson L
Mol Pharmacol; 1989 May; 35(5):635-42. PubMed ID: 2725473
[TBL] [Abstract][Full Text] [Related]
13. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
Bai R; Cichacz ZA; Herald CL; Pettit GR; Hamel E
Mol Pharmacol; 1993 Oct; 44(4):757-66. PubMed ID: 8232226
[TBL] [Abstract][Full Text] [Related]
14. Regulation of size and birefringence of the in vivo mitotic apparatus.
Rebhun LI; Mellon M; Jemiolo D; Nath J; Ivy N
J Supramol Struct; 1974; 2(2-4):466-85. PubMed ID: 4373619
[No Abstract] [Full Text] [Related]
15. Antitubulin activities of ansamitocins and maytansinoids.
Ikeyama S; Takeuchi M
Biochem Pharmacol; 1981 Sep; 30(17):2421-5. PubMed ID: 21043240
[TBL] [Abstract][Full Text] [Related]
16. Rhizoxin binding to tubulin at the maytansine-binding site.
Takahashi M; Iwasaki S; Kobayashi H; Okuda S; Murai T; Sato Y
Biochim Biophys Acta; 1987 Dec; 926(3):215-23. PubMed ID: 3120782
[TBL] [Abstract][Full Text] [Related]
17. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
18. Studies on macrocyclic lactone antibiotics. XI. Anti-mitotic and anti-tubulin activity of new antitumor antibiotics, rhizoxin and its homologues.
Takahashi M; Iwasaki S; Kobayashi H; Okuda S; Murai T; Sato Y; Haraguchi-Hiraoka T; Nagano H
J Antibiot (Tokyo); 1987 Jan; 40(1):66-72. PubMed ID: 3606749
[TBL] [Abstract][Full Text] [Related]
19. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
Derry WB; Wilson L; Jordan MA
Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803
[TBL] [Abstract][Full Text] [Related]
20. Distribution of fluorescently labeled tubulin injected into sand dollar eggs from fertilization through cleavage.
Hamaguchi Y; Toriyama M; Sakai H; Hiramoto Y
J Cell Biol; 1985 Apr; 100(4):1262-72. PubMed ID: 3920225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
